AT348097T

Guanidino compounds as melanocortin-4 receptor (mc4-r) agonists

Abstract

A compound of formula ** ** wherein X and Y are independently selected from the group consisting of N select, C = O, NR9, O, S, (CR6R7) n and C (= O) - (CR6R7) n; n is 1, 2 or 3; wherein when X is N, then Y is not N, provided that when X is N, then Y can still be NH; wherein when Y is N, then X is not N, provided that when Y is N, then X can still be NH; wherein when X is CH2, then Y is not CH2; wherein when X is NH, then Y is not NH; D is selected from the group consisting of N, CH and C; L is NH, O, C (O) NHC (O), OC (O) or a covalent bond; W is selected from the group consisting of Z1, Z2 and Z3 are independently selected from the group consisting of CR8 and N; R1 is selected from the group consisting of arylalkyl, heteroarylalkyl, aryl, heteroaryl, heterocyclyl, cycloalkyl, heterocyclylalkyl, cycloalkylalkyl, alkenyl, alkynyl and substituted and unsubstituted alkyl; R2 is H; R3 is selected from the group consisting of alkyl, alkenyl, alkynyl, cycloalkyl, heteroaryl, heterocyclyl, heterocyclylalkyl, arylalkyl, heteroarylalkyl and cycloalkylalkyl substituted and unsubstituted, or R2 and R3 may be joined to form a ring containing at least two atoms N.

Term

No projected expiry on record.

  1. Priority
  2. Filed
  3. Granted
  4. Today

22 members in 10 offices

This recordMember, by publication datePriority claim

Priority claims1

Priority claims
DocumentOfficeKindDate
28284701United States of AmericaP

Members22

Family members, oldest first
DocumentOfficeKind
WO02081443A1World Intellectual Property Organization (WIPO)A1
US2002193595A1United States of AmericaA1
EP1385823A1European Patent Office (EPO)A1
US2004024211A1United States of AmericaA1
US6716840B2United States of AmericaB2
JP2004535378AJapanA
US2004248895A1United States of AmericaA1
EP1385823A4European Patent Office (EPO)A4
US2005038027A1United States of AmericaA1
US6960582B2United States of AmericaB2
EP1385823B1European Patent Office (EPO)B1
AT348097TThis recordAustriaT
DE60216747D1GermanyD1
PT1385823EPortugalE
US7189727B2United States of AmericaB2
DK1385823T3DenmarkT3
EP1767525A1European Patent Office (EPO)A1
ES2278016T3SpainT3
DE60216747T2GermanyT2
JP4172541B2JapanB2
US7456183B2United States of AmericaB2
CY1107442T1CyprusT1